APA (7th ed.) Citation

Laliberté, F., Pilon, D., Raut, M., Nelson, W., Olson, W., Germain, G., . . . Lefebvre, P. (2014). Hospital Length Of Stay: Does Rivaroxaban Reduce Inpatient Stay Compared To Warfarin Among Patients With Non-Valvular Atrial Fibrillation? Value in Health, 17(3), A102. https://doi.org/10.1016/j.jval.2014.03.598

Chicago Style (17th ed.) Citation

Laliberté, F., D. Pilon, M. Raut, W.W Nelson, W.H Olson, G. Germain, J.R Schein, and P. Lefebvre. "Hospital Length Of Stay: Does Rivaroxaban Reduce Inpatient Stay Compared To Warfarin Among Patients With Non-Valvular Atrial Fibrillation?" Value in Health 17, no. 3 (2014): A102. https://doi.org/10.1016/j.jval.2014.03.598.

MLA (9th ed.) Citation

Laliberté, F., et al. "Hospital Length Of Stay: Does Rivaroxaban Reduce Inpatient Stay Compared To Warfarin Among Patients With Non-Valvular Atrial Fibrillation?" Value in Health, vol. 17, no. 3, 2014, p. A102, https://doi.org/10.1016/j.jval.2014.03.598.